FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

David Elder

Research Profile

Disorders

Anatomy

Chemicals & Drugs

Concepts & Ideas

Procedures

Physiology

Disease Progression

Co-author Network

Publications

TOP 3
Thomas R Fears; DuPont Guerry; Allan Halpern; Elizabeth A Holly; Richard W Sagebiel; David E Elder; Margaret A Tucker
Sunbeds and sunlamps: who used them and their risk for melanoma.
Julia Newton-Bishop; Yu-Mei Chang; Faye Elliott; May Chan; Susan Leake; Birute Karpavicius; Sue Haynes; Elaine Fitzgibbon; Kairen Kukalizch; Juliette A Randerson-Moor; David E Elder; D Timothy Bishop; Jennifer H Barrett
Relationship between sun exposure and melanoma risk for tumours in different body sites in a large case-control study in a temperate climate.
Peter Kanetsky; Saarene Panossian; David E Elder; DuPont Guerry; Michael E Ming; Lynn Schuchter; Timothy R Rebbeck
Does MC1R genotype convey information about melanoma risk beyond risk phenotypes?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of David Elder (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Thomas R Fears; DuPont Guerry; Allan Halpern; Elizabeth A Holly; Richard W Sagebiel; David E Elder; Margaret A Tucker
Sunbeds and sunlamps: who used them and their risk for melanoma.
Pigment cell & melanoma research 2011;24(3):574-81.
2011: Julia Newton-Bishop; Yu-Mei Chang; Faye Elliott; May Chan; Susan Leake; Birute Karpavicius; Sue Haynes; Elaine Fitzgibbon; Kairen Kukalizch; Juliette A Randerson-Moor; David E Elder; D Timothy Bishop; Jennifer H Barrett
Relationship between sun exposure and melanoma risk for tumours in different body sites in a large case-control study in a temperate climate.
European journal of cancer (Oxford, England : 1990) 2011;47(5):732-41.
2010: Peter Kanetsky; Saarene Panossian; David E Elder; DuPont Guerry; Michael E Ming; Lynn Schuchter; Timothy R Rebbeck
Does MC1R genotype convey information about melanoma risk beyond risk phenotypes?
Cancer 2010;116(10):2416-28.
2010: David E Elder
Prognostic models for melanoma.
Journal of cutaneous pathology 2010;37 Suppl 1():68-75.
2010: Rosalynn M Nazarian; Victor G Prieto; David E Elder; Lyn M Duncan
Melanoma biomarker expression in melanocytic tumor progression: a tissue microarray study.
Journal of cutaneous pathology 2010;37 Suppl 1():41-7.
2010: David E Elder
Dysplastic naevi: an update.
Histopathology 2010;56(1):112-20.
2009: Julia Newton-Bishop; Samantha Beswick; Juliette Randerson-Moor; Yu-Mei Chang; Paul Affleck; Faye Elliott; May Chan; Susan Leake; Birute Karpavicius; Sue Haynes; Kairen Kukalizch; Linda Whitaker; Sharon Jackson; Edwina Gerry; Clarissa Nolan; Chandra Bertram; Jerry Marsden; David E Elder; Jennifer H Barrett; D Timothy Bishop
Serum 25-hydroxyvitamin D3 levels are associated with breslow thickness at presentation and survival from melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(32):5439-44.
2009: Hong Yu; Ronan McDaid; John Lee; Patricia Possik; Ling Li; Suresh M Kumar; David E Elder; Patricia Van Belle; Phyllis A Gimotty; Matt Guerra; Rachel Hammond; Katherine L Nathanson; Maria Dalla Palma; Meenhard Herlyn; Xiaowei Xu
The role of BRAF mutation and p53 inactivation during transformation of a subpopulation of primary human melanocytes.
The American journal of pathology 2009;174(6):2367-77.
2009: Michael T Tetzlaff; Xiaowei Xu; David E Elder; Rosalie Elenitsas
Angiomatoid Spitz nevus: a clinicopathological study of six cases and a review of the literature.
Journal of cutaneous pathology 2009;36(4):471-6.
2009: Keiran Smalley; Min Xiao; J Villanueva; Thiennga K Nguyen; Keith T Flaherty; R Letrero; Patricia Van Belle; David E Elder; Y Wang; Katherine L Nathanson; Meenhard Herlyn
CRAF inhibition induces apoptosis in melanoma cells with non-V600E BRAF mutations.
Oncogene 2009;28(1):85-94.
2008: Alireza Zarineh; Milena E Kozovska; William G Brown; David E Elder; Michael S Rabkin
Smooth muscle hamartoma associated with a congenital pattern melanocytic nevus, a case report and review of the literature.
Journal of cutaneous pathology 2008;35 Suppl 1():83-6.
2008: Maria Concetta Fargnoli; Maria Concetia Fargnoli; Kris Pike; Ruth M Pfeiffer; Shirley Tsang; Ester Rozenblum; David J Munroe; Yelena Golubeva; Donato Calista; Stefania Seidenari; Daniela Massi; Paolo Carli; Jürgen Bauer; David E Elder; Boris C Bastian; Ketty Peris; Maria T Landi
MC1R variants increase risk of melanomas harboring BRAF mutations.
The Journal of investigative dermatology 2008;128(10):2485-90.
2008: Keiran Smalley; Mercedes Lioni; Maurizia Dalla Palma; Min Xiao; Brijal Desai; Suzanne Egyhazi; Johan Hansson; Hong Wu; Alastair J King; Patricia Van Belle; David E Elder; Keith T Flaherty; Meenhard Herlyn; Katherine L Nathanson
Increased cyclin D1 expression can mediate BRAF inhibitor resistance in BRAF V600E-mutated melanomas.
Molecular cancer therapeutics 2008;7(9):2876-83.
2008: Bonnie E Gould Rothberg; Christopher B Moeder; Harriet M Kluger; Ruth Halaban; David E Elder; George F Murphy; Alexander Lazar; Victor Prieto; Lynn McDivitt Duncan; David L Rimm
Nuclear to non-nuclear Pmel17/gp100 expression (HMB45 staining) as a discriminator between benign and malignant melanocytic lesions.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2008;21(9):1121-9.
2008: Keith T Flaherty; Joan Schiller; Lynn Schuchter; Glenn Liu; David A Tuveson; Maryann Redlinger; Chetan Lathia; Chenghua Xia; Oana Petrenciuc; Sunil R Hingorani; Michael Jacobetz; Patricia Van Belle; David E Elder; Marcia S Brose; Barbara L Weber; Mark R Albertini; Peter J O'Dwyer
A phase I trial of the oral, multikinase inhibitor sorafenib in combination with carboplatin and paclitaxel.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(15):4836-42.
2008: Kevin Brown; Stuart Macgregor; Grant W Montgomery; David Craig; Zhen Zhen Zhao; Kelly Iyadurai; Anjali K Henders; Nils Homer; Megan J Campbell; Mitchell Stark; Shane Thomas; Helen Schmid; Elizabeth A Holland; Elizabeth M Gillanders; David L Duffy; Judith A Maskiell; Jodie Jetann; Megan Ferguson; Dietrich A Stephan; Anne E Cust; David Whiteman; Adele Green; Håkan Olsson; Susana Puig; Paola Ghiorzo; Johan Hansson; Florence Demenais; Alisa M Goldstein; Nelleke A Gruis; David E Elder; Julia Newton Bishop; Richard F Kefford; Graham G Giles; Bruce K Armstrong; Joanne F Aitken; John L Hopper; Nicholas G Martin; Jeffrey M. Trent; Graham J Mann; Nicholas K Hayward
Common sequence variants on 20q11.22 confer melanoma susceptibility.
Nature genetics 2008;40(7):838-40.
2008: Xiaowei Xu; Phyllis A Gimotty; DuPont Guerry; Giorgos Karakousis; Patricia Van Belle; Haohai Liang; kathleen montone; Theresa L Pasha; Michael E Ming; Geza Acs; Michael Feldman; Stephen Barth; Rachel Hammond; Rosalie Elenitsas; Paul J Zhang; David E Elder
Lymphatic invasion revealed by multispectral imaging is common in primary melanomas and associates with prognosis.
Human pathology 2008;39(6):901-9.
2008: Mark Harland; Alisa M Goldstein; Kairen Kukalizch; Claire Taylor; David Hogg; Susana Puig; Celia Badenas; Nelleke Gruis; Jeanet ter Huurne; Wilma Bergman; Nicholas K Hayward; Mitchell Stark; Hensin Tsao; Margaret A Tucker; Maria Teresa Landi; Giovanna Bianchi Scarra; Paola Ghiorzo; Peter Kanetsky; David E Elder; Graham J Mann; Elizabeth A Holland; D Timothy Bishop; Julia Newton Bishop
A comparison of CDKN2A mutation detection within the Melanoma Genetics Consortium (GenoMEL).
European journal of cancer (Oxford, England : 1990) 2008;44(9):1269-74.
2008: M Fukunaga-Kalabis; G Martinez; S M Telson; Zhao-Jun Liu; Klara Balint; I Juhasz; David E Elder; Bernard Perbal; Meenhard Herlyn
Downregulation of CCN3 expression as a potential mechanism for melanoma progression.
Oncogene 2008;27(18):2552-60.
2008: Michael T Tetzlaff; Peter Liu; Bert W O'Malley; Virginia A LiVolsi; David E Elder
Report of a case of sinonasal undifferentiated carcinoma arising in a background of extensive nasal gliomatosis.
Head & neck 2008;30(4):549-55.
2007: Giorgos C Karakousis; Phyllis A Gimotty; Brian J Czerniecki; David E Elder; Rosalie Elenitsas; Michael E Ming; Douglas L Fraker; DuPont Guerry; Francis R Spitz
Regional nodal metastatic disease is the strongest predictor of survival in patients with thin vertical growth phase melanomas: a case for SLN Staging biopsy in these patients.
Annals of surgical oncology 2007;14(5):1596-603.
2007: Rolf Swoboda; Rajasekharan Somasundaram; Laura Caputo; Elizabeth M Ochoa; Phyllis A Gimotty; Francesco M Marincola; Patricia Van Belle; Stephen Barth; David E Elder; DuPont Guerry; Brian J Czerniecki; Lynn Schuchter; Robert H Vonderheide; Dorothee Herlyn
Shared MHC class II-dependent melanoma ribosomal protein L8 identified by phage display.
Cancer research 2007;67(8):3555-9.
2007: Phyllis A Gimotty; David E Elder; Douglas L Fraker; Jeffrey Botbyl; Kimberly Sellers; Rosalie Elenitsas; Michael E Ming; Lynn Schuchter; Francis R Spitz; Brian J Czerniecki; DuPont Guerry
Identification of high-risk patients among those diagnosed with thin cutaneous melanomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(9):1129-34.
2007: C Suzanne Lea; Elizabeth A Holly; Patricia Hartge; Jennifer Shuwen Lee; DuPont Guerry; David E Elder; Allan C Halpern; Richard W Sagebiel; Margaret A Tucker
Reproductive risk factors for cutaneous melanoma in women: a case-control study.
American journal of epidemiology 2007;165(5):505-13.
2007: Alisa M Goldstein; May Chan; Mark Harland; Nicholas K Hayward; Florence Demenais; Tim BISHOP; Esther Azizi; Wilma Bergman; Giovanna Bianchi-Scarra; William Bruno; Donato Calista; Lisa A Cannon Albright; Valerie Chaudru; Agnes Chompret; Francisco Cuellar; David E Elder; Paola Ghiorzo; Elizabeth M Gillanders; Nelleke A Gruis; Johan Hansson; David Hogg; Elizabeth A Holland; Peter Kanetsky; Richard F Kefford; Maria Teresa Landi; Julie Lang; Sancy A Leachman; Rona M MacKie; Veronica Magnusson; Graham J Mann; Julia Newton Bishop; Jane M Palmer; Susana Puig; Joan A Puig-Butille; Mitchell Stark; Hensin Tsao; Margaret A Tucker; Linda Whitaker; Emanuel Yakobson
Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents.
Journal of medical genetics 2007;44(2):99-106.
2006: Laura L Kruper; Francis R Spitz; Brian J Czerniecki; Douglas L Fraker; Anne Blackwood-Chirchir; Michael E Ming; David E Elder; Rosalie Elenitsas; DuPont Guerry; Phyllis A Gimotty
Predicting sentinel node status in AJCC stage I/II primary cutaneous melanoma.
Cancer 2006;107(10):2436-45.
2006: Alisa M Goldstein; May Chan; Mark Harland; Elizabeth M Gillanders; Nicholas K Hayward; Marie-Francoise Avril; Esther Azizi; Giovanna Bianchi-Scarra; Tim BISHOP; Brigitte Bressac-de Paillerets; William Bruno; Donato Calista; Lisa A Cannon Albright; Florence Demenais; David E Elder; Paola Ghiorzo; Nelleke A Gruis; Johan Hansson; David Hogg; Elizabeth A Holland; Peter Kanetsky; Richard F Kefford; Maria Teresa Landi; Julie Lang; Sancy A Leachman; Rona M Mackie; Veronica Magnusson; Graham J Mann; Kristin Niendorf; Julia Newton Bishop; Jane M Palmer; Susana Puig; Joan A Puig-Butille; Femke A de Snoo; Mitchell Stark; Hensin Tsao; Margaret A Tucker; Linda Whitaker; Emanuel Yakobson
High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL.
Cancer research 2006;66(20):9818-28.
2006: Tianqian Zhang; Rajasekharan Somasundaram; Carola Berking; Laura Caputo; Patricia Van Belle; David E Elder; Brian J Czerniecki; Susan Hotz; Lynn Schuchter; Francis R Spitz; Klara Berencsi; Pyapalli Rani; Francesco M Marincola; Ruihua Qiu; Dorothee Herlyn
Preferential involvement of CX chemokine receptor 4 and CX chemokine ligand 12 in T-cell migration toward melanoma cells.
Cancer biology & therapy 2006;5(10):1304-12.
2006: David T Dicker; Jeremy Lerner; Patricia Van Belle; Stephen F Barth; DuPont Guerry; Meenhard Herlyn; David E Elder; Wafik S El-Deiry
Differentiation of normal skin and melanoma using high resolution hyperspectral imaging.
Cancer biology & therapy 2006;5(8):1033-8.
2006: Thomas R Fears; DuPont Guerry; Ruth M Pfeiffer; Richard W Sagebiel; David E Elder; Allan C Halpern; Elizabeth A Holly; Patricia Hartge; Margaret A Tucker
Identifying individuals at high risk of melanoma: a practical predictor of absolute risk.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(22):3590-6.
2006: Maria Teresa Landi; Jürgen Bauer; Ruth M Pfeiffer; David E Elder; Benjamin Hulley; Paola Minghetti; Donato Calista; Peter Kanetsky; Daniel Pinkel; Boris C Bastian
MC1R germline variants confer risk for BRAF-mutant melanoma.
Science (New York, N.Y.) 2006;313(5786):521-2.
2006: David E Elder
Pathology of melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(7 Pt 2):2308s-2311s.
2006: Michael B Atkins; David E Elder; Richard Essner; Keith T Flaherty; Thomas F Gajewski; Frank G Haluska; Patrick Hwu; Ulrich Keilholz; John M Kirkwood; James W Mier; Merrick I Ross; Craig L Slingluff; vernon sondak; Jeffrey A Sosman; Martin A Weinstock; Laura King
Innovations and challenges in melanoma: summary statement from the first Cambridge conference.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(7 Pt 2):2291s-2296s.
2006: Giorgos C Karakousis; Phyllis A Gimotty; Jeffrey Botbyl; Susan Kesmodel; David E Elder; Rosalie Elenitsas; Michael E Ming; DuPont Guerry; Douglas L Fraker; Brian J Czerniecki; Francis R Spitz
Predictors of regional nodal disease in patients with thin melanomas.
Annals of surgical oncology 2006;13(4):533-41.
2006: Rajasekharan Somasundaram; Rolf Swoboda; Laura Caputo; Laszlo Otvos; Barbara Weber; Patricia Volpe; Patricia Van Belle; Susan Hotz; David E Elder; Francesco M Marincola; Lynn Schuchter; DuPont Guerry; Brian J Czerniecki; Dorothee Herlyn
Human leukocyte antigen-A2-restricted CTL responses to mutated BRAF peptides in melanoma patients.
Cancer research 2006;66(6):3287-93.
2006: David E Elder
Precursors to melanoma and their mimics: nevi of special sites.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2006;19 Suppl 2():S4-20.
2006: Richard A Scolyer; John F Thompson; Stanley W McCarthy; Geoffrey M Strutton; David E Elder
Incomplete biopsy of melanocytic lesions can impair the accuracy of pathological diagnosis.
The Australasian journal of dermatology 2006;47(1):71-3; author reply 74-5.
2005: Phyllis A Gimotty; Patricia Van Belle; David E Elder; Todd Murry; Kathleen T Montone; Xiaowei Xu; Susan Hotz; Shane Raines; Michael E Ming; Peter Wahl; DuPont Guerry
Biologic and prognostic significance of dermal Ki67 expression, mitoses, and tumorigenicity in thin invasive cutaneous melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(31):8048-56.
2005: Dong Fang; Thiennga K Nguyen; Kim Leishear; Rena Finko; Angela N Kulp; Susan Hotz; Patricia Van Belle; Xiaowei Xu; David E Elder; Meenhard Herlyn
A tumorigenic subpopulation with stem cell properties in melanomas.
Cancer research 2005;65(20):9328-37.
2005: David E Elder; Phyllis A Gimotty; DuPont Guerry
Cutaneous melanoma: estimating survival and recurrence risk based on histopathologic features.
Dermatologic therapy 2005;18(5):369-85.
2005: Susan Kesmodel; Giorgos C Karakousis; Jeffrey Botbyl; Robert Canter; Robert T Lewis; Peter M Wahl; Kyla P Terhune; Abass Alavi; David E Elder; Michael E Ming; DuPont Guerry; Phyllis A Gimotty; Douglas L Fraker; Brian J Czerniecki; Francis R Spitz
Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas.
Annals of surgical oncology 2005;12(6):449-58.
2005: Suresh M Kumar; Geza Acs; Dong Fang; Meenhard Herlyn; David E Elder; Xiaowei Xu
Functional erythropoietin autocrine loop in melanoma.
The American journal of pathology 2005;166(3):823-30.
2004: Joni L Rutter; Christina M Bromley; Alisa M Goldstein; David E Elder; Elizabeth A Holly; DuPont Guerry; Patricia Hartge; Jeffery Struewing; David Hogg; Allan C Halpern; Richard W Sagebiel; Margaret A Tucker
Heterogeneity of risk for melanoma and pancreatic and digestive malignancies: a melanoma case-control study.
Cancer 2004;101(12):2809-16.
2004: Cynthia Kucher; Paul J Zhang; Theresa L Pasha; Rosalie Elenitsas; Hong Wu; Michael E Ming; David E Elder; Xiaowei Xu
Expression of Melan-A and Ki-67 in desmoplastic melanoma and desmoplastic nevi.
The American Journal of dermatopathology 2004;26(6):452-7.
2004: Tamar Giorgadze; Paul J Zhang; Theresa L Pasha; P S Coogan; Geza Acs; David E Elder; Xiaowei Xu
Lymphatic vessel density is significantly increased in melanoma.
Journal of cutaneous pathology 2004;31(10):672-7.
2004: David E Elder; Xiaowei Xu
The approach to the patient with a difficult melanocytic lesion.
Pathology 2004;36(5):428-34.
2004: Richard A Scolyer; Stanley W McCarthy; David E Elder
Frontiers in melanocytic pathology.
Pathology 2004;36(5):385-6.
2004: Phyllis A Gimotty; DuPont Guerry; Michael E Ming; Rosalie Elenitsas; Xiaowei Xu; Brian J Czerniecki; Francis R Spitz; Lynn Schuchter; David E Elder
Thin primary cutaneous malignant melanoma: a prognostic tree for 10-year metastasis is more accurate than American Joint Committee on Cancer staging.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(18):3668-76.
2004: Michael Shapiro; Mary-Margaret Chren; Ross M Levy; David E Elder; Philip E LeBoit; Martin C Mihm; David J Margolis; Phyllis A Gimotty; Michael E Ming
Variability in nomenclature used for nevi with architectural disorder and cytologic atypia (microscopically dysplastic nevi) by dermatologists and dermatopathologists.
Journal of cutaneous pathology 2004;31(8):523-30.
2004: Xiaowei Xu; David E Elder
A practical approach to selected problematic melanocytic lesions.
American journal of clinical pathology 2004;121 Suppl():S3-32.
2004: Amy E Millen; Margaret A Tucker; Patricia Hartge; Allan C Halpern; David E Elder; DuPont Guerry; Elizabeth A Holly; Richard W Sagebiel; Nancy Potischman
Diet and melanoma in a case-control study.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2004;13(6):1042-51.
2004: Rebecca Lintner; Erum N Ilyas; David E Elder; Warren R Heymann
Nodule on the back of a 73-year-old woman--case.
Archives of dermatology 2004;140(5):609-14.
2004: Carola Berking; Richelle Takemoto; Kapaettu Satyamoorthy; Takahashi Shirakawa; Malihe Eskandarpour; Johan Hansson; Patricia A VanBelle; David E Elder; Meenhard Herlyn
Induction of melanoma phenotypes in human skin by growth factors and ultraviolet B.
Cancer research 2004;64(3):807-11.
2004: Xiaowei Xu; Kirsten S W Bellucci; Rosalie Elenitsas; David E Elder
Cellular nodules in congenital pattern nevi.
Journal of cutaneous pathology 2004;31(2):153-9.
2003: Xiaowei Xu; Paul J Zhang; David E Elder
Tyrosinase expression in malignant melanoma, desmoplastic melanoma, and peripheral nerve tumors.
Archives of pathology & laboratory medicine 2003;127(9):1083-4; author reply 1084-5.
2003: Alain Spatz; Martin G Cook; David E Elder; Michael Piepkorn; Dirk J Ruiter; Raymond L Barnhill
Interobserver reproducibility of ulceration assessment in primary cutaneous melanomas.
European journal of cancer (Oxford, England : 1990) 2003;39(13):1861-5.
2003: Kapaettu Satyamoorthy; Gang Li; Michelle R Gerrero; Marcia S Brose; Patricia Volpe; Barbara L Weber; Patricia Van Belle; David E Elder; Meenhard Herlyn
Constitutive mitogen-activated protein kinase activation in melanoma is mediated by both BRAF mutations and autocrine growth factor stimulation.
Cancer research 2003;63(4):756-9.
2003: John T Seykora; Debra M Jih; Rosalie Elenitsas; Wen-Hwai Horng; David E Elder
Gene expression profiling of melanocytic lesions.
The American Journal of dermatopathology 2003;25(1):6-11.
2002: Timothy D Anderson; Randal S Weber; DuPont Guerry; David E Elder; Lynn Schuchter; Laurie A Loevner; David I Rosenthal
Desmoplastic neurotropic melanoma of the head and neck: the role of radiation therapy.
Head & neck 2002;24(12):1068-71.
2002: Richard F Kefford; Julia Newton Bishop; Margaret Tucker; Brigitte Bressac De-Paillerets; Giovanna Bianchi-Scarrá; Wilma Bergman; Alisa Goldstein; Susana Puig; Rona Mackie; David E Elder; Johan Hansson; Nicholas Hayward; David Hogg; Håkan Olsson
Genetic testing for melanoma.
The lancet oncology 2002;3(11):653-4.
2002: Kapaettu Satyamoorthy; Gang Li; Patricia Van Belle; David E Elder; Meenhard Herlyn
A versatile method for the removal of melanin from ribonucleic acids in melanocytic cells.
Melanoma research 2002;12(5):449-52.
2002: Phyllis A Gimotty; DuPont Guerry; David E Elder
Validation of prognostic models for melanoma.
American journal of clinical pathology 2002;118(4):489-91.
2002: Timothy R Rebbeck; Peter Kanetsky; Amy H Walker; Robin Holmes; Allan C Halpern; Lynn Schuchter; David E Elder; DuPont Guerry
P gene as an inherited biomarker of human eye color.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002;11(8):782-4.
2002: Thomas R Fears; Cameron C Bird; DuPont Guerry; Richard W Sagebiel; Mitchell H Gail; David E Elder; Allan C Halpern; Elizabeth A Holly; Patricia Hartge; Margaret A Tucker
Average midrange ultraviolet radiation flux and time outdoors predict melanoma risk.
Cancer research 2002;62(14):3992-6.
2002: Karen S McGinnis; Stuart R Lessin; David E Elder; DuPont Guerry; Lynn Schuchter; Michael E Ming; Rosalie Elenitsas
Pathology review of cases presenting to a multidisciplinary pigmented lesion clinic.
Archives of dermatology 2002;138(5):617-21.
2002: M Anne Blackwood; Robin Holmes; Marie Synnestvedt; Megan Young; Cicily George; Hannah Yang; David E Elder; Lynn Schuchter; DuPont Guerry; Arupa Ganguly
Multiple primary melanoma revisited.
Cancer 2002;94(8):2248-55.
2002: Alisa M Goldstein; A Chidambaram; Allan C Halpern; Elizabeth A Holly; D Guerry IV; Richard W Sagebiel; David E Elder; Margaret A Tucker
Rarity of CDK4 germline mutations in familial melanoma.
Melanoma research 2002;12(1):51-5.
2002: Dirk Ruiter; Thomas Bogenrieder; David E Elder; Meenhard Herlyn
Melanoma-stroma interactions: structural and functional aspects.
The lancet oncology 2002;3(1):35-43.
2002: Xiaowei Xu; Albert Y Chu; Theresa L Pasha; David E Elder; Paul J Zhang
Immunoprofile of MITF, tyrosinase, melan-A, and MAGE-1 in HMB45-negative melanomas.
The American journal of surgical pathology 2002;26(1):82-7.
2001: John K Wildemore; Lynn Schuchter; Rosemarie Mick; Marie Synnestvedt; Rosalie Elenitsas; Isabelle Bedrosian; Brian J Czerniecki; DuPont Guerry; Stuart R Lessin; David E Elder; Louis P Bucky
Locally recurrent malignant melanoma characteristics and outcomes: a single-institution study.
Annals of plastic surgery 2001;46(5):488-94.
2001: Jian Li; S Pereira; Patricia Van Belle; P Tsui; David E Elder; David W Speicher; K Deen; Alban Linnenbach; Rajasekharan Somasundaram; Rolf Swoboda; Dorothee Herlyn
Isolation of the melanoma-associated antigen p23 using antibody phage display.
Journal of immunology (Baltimore, Md. : 1950) 2001;166(1):432-8.
2000: Paul J Christos; Susan A Oliveria; Marianne Berwick; David E Elder; Marie Synnestvedt; JA Fine; RL Barnhill; Allan C Halpern
Signs and symptoms of melanoma in older populations.
Journal of clinical epidemiology 2000;53(10):1044-53.
2000: Isabelle Bedrosian; Mark Faries; DuPont Guerry; Rosalie Elenitsas; Lynn Schuchter; Rosemarie Mick; Francis R Spitz; Louis P Bucky; Abass Alavi; David E Elder; Douglas L Fraker; Brian J Czerniecki
Incidence of sentinel node metastasis in patients with thin primary melanoma (< or = 1 mm) with vertical growth phase.
Annals of surgical oncology 2000;7(4):262-7.
2000: Mei-Yu Hsu; Friedegund Meier; Mark Nesbit; JY Hsu; Patricia Van Belle; David E Elder; Meenhard Herlyn
E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors.
The American journal of pathology 2000;156(5):1515-25.
2000: Stephen Lyle; KE Salhany; David E Elder
TIA-1 positive tumor-infiltrating lymphocytes in nevi and melanomas.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2000;13(1):52-5.
2000: Friedegund Meier; Mark Nesbit; Mei-Yu Hsu; B Martin; Patricia Van Belle; David E Elder; G Schaumburg-Lever; C Garbe; T M Walz; P Donatien; Timothy M Crombleholme; Meenhard Herlyn
Human melanoma progression in skin reconstructs : biological significance of bFGF.
The American journal of pathology 2000;156(1):193-200.
1999: Stephen Lyle; Melpo Christofidou-Solomidou; Yaping Liu; David E Elder; Steven M Albelda; George Cotsarelis
Human hair follicle bulge cells are biochemically distinct and possess an epithelial stem cell phenotype.
The journal of investigative dermatology. Symposium proceedings / the Society for Investigative Dermatology, Inc. [and] European Society for Dermatological Research 1999;4(3):296-301.
1999: Debra M Jih; David E Elder; Rosalie Elenitsas
A histopathologic evaluation of vulvar melanosis.
Archives of dermatology 1999;135(7):857-8.
1999: Isabelle Bedrosian; AM Scheff; Rosemarie Mick; Linda S Callans; Louis P Bucky; Francis R Spitz; C Helsabeck; David E Elder; Abass Alavi; D F Fraker; Brian J Czerniecki
99mTc-human serum albumin: an effective radiotracer for identifying sentinel lymph nodes in melanoma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(7):1143-8.
1999: Patricia Van Belle; Rosalie Elenitsas; Kapaettu Satyamoorthy; J T Wolfe; DuPont Guerry; L Schuchter; T J Van Belle; S Albelda; P Tahin; Meenhard Herlyn; David E Elder
Progression-related expression of beta3 integrin in melanomas and nevi.
Human pathology 1999;30(5):562-7.
1999: David E Elder; George F Murphy; R L Lavker
Wallace H. Clark, Jr., MD: a biography and annotated bibliography.
Human pathology 1999;30(5):491-7.
1999: Debra M Jih; Stephen Lyle; Rosalie Elenitsas; David E Elder; George Cotsarelis
Cytokeratin 15 expression in trichoepitheliomas and a subset of basal cell carcinomas suggests they originate from hair follicle stem cells.
Journal of cutaneous pathology 1999;26(3):113-8.
1999: David E Elder
Tumor progression, early diagnosis and prognosis of melanoma.
Acta oncologica (Stockholm, Sweden) 1999;38(5):535-47.
1998: Mei-Yu Hsu; D T Shih; Friedegund Meier; Patricia Van Belle; JY Hsu; David E Elder; C A Buck; Meenhard Herlyn
Adenoviral gene transfer of beta3 integrin subunit induces conversion from radial to vertical growth phase in primary human melanoma.
The American journal of pathology 1998;153(5):1435-42.
1998: Stephen Lyle; Melpo Christofidou-Solomidou; Yaping Liu; David E Elder; Steven M Albelda; George Cotsarelis
The C8/144B monoclonal antibody recognizes cytokeratin 15 and defines the location of human hair follicle stem cells.
Journal of cell science 1998;111 ( Pt 21)():3179-88.
1998: B F Kammen; David E Elder; Douglas L Fraker; Evan S Siegelman
Extraadrenal myelolipoma: MR imaging findings.
AJR. American journal of roentgenology 1998;171(3):721-3.
1998: ES Atillasoy; John T Seykora; P W Soballe; Rosalie Elenitsas; Mark Nesbit; David E Elder; Kathleen T Montone; Edward R Sauter; Meenhard Herlyn
UVB induces atypical melanocytic lesions and melanoma in human skin.
The American journal of pathology 1998;152(5):1179-86.
1997: Kathleen T Montone; Patricia Van Belle; Rosalie Elenitsas; David E Elder
Proto-oncogene c-kit expression in malignant melanoma: protein loss with tumor progression.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1997;10(9):939-44.
1997: Kapaettu Satyamoorthy; E DeJesus; Alban Linnenbach; Barbara J Kraj; D L Kornreich; S Rendle; David E Elder; Meenhard Herlyn
Melanoma cell lines from different stages of progression and their biological and molecular analyses.
Melanoma research 1997;7 Suppl 2():S35-42.
1997: Margaret A Tucker; Allan C Halpern; Elizabeth A Holly; Patricia Hartge; David E Elder; Richard W Sagebiel; DuPont Guerry; Wallace H Clark
Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma.
JAMA : the journal of the American Medical Association 1997;277(18):1439-44.
1997: S Pereira; Haruhiko Maruyama; D Siegel; Patricia Van Belle; David E Elder; P Curtis; Dorothee Herlyn
A model system for detection and isolation of a tumor cell surface antigen using antibody phage display.
Journal of immunological methods 1997;203(1):11-24.
1997: S Pereira; Patricia Van Belle; David E Elder; Haruhiko Maruyama; Lutz Jacob; M Sivanandham; Marc K Wallack; D Siegel; Dorothee Herlyn
Combinatorial antibodies against human malignant melanoma.
Hybridoma 1997;16(1):11-6.
1996: David E Elder; Patricia Van Belle; Rosalie Elenitsas; Allan C Halpern; DuPont Guerry
Neoplastic progression and prognosis in melanoma.
Seminars in cutaneous medicine and surgery 1996;15(4):336-48.
1996: J Seykora; David E Elder
Dysplastic nevi and other risk markers for melanoma.
Seminars in oncology 1996;23(6):682-7.
1996: M P Boncoeur-Martel; Laurie A Loevner; David M Yousem; David E Elder; Gregory S Weinstein
Granular cell myoblastoma of the cervical esophagus: MR findings.
AJNR. American journal of neuroradiology 1996;17(9):1794-7.
1996: Lynn Schuchter; D J Schultz; Marie Synnestvedt; Bruce J Trock; DuPont Guerry; David E Elder; Rosalie Elenitsas; W H Clark; Allan C Halpern
A prognostic model for predicting 10-year survival in patients with primary melanoma. The Pigmented Lesion Group.
Annals of internal medicine 1996;125(5):369-75.
1996: Patricia Van Belle; Ulrich Rodeck; Isaac Nuamah; Allan C Halpern; David E Elder
Melanoma-associated expression of transforming growth factor-beta isoforms.
The American journal of pathology 1996;148(6):1887-94.
1996: David E Elder
Pagetoid melanocytosis.
The American journal of surgical pathology 1996;20(5):642-3.
1995: Susan Baer; D Schultz; Marie Synnestvedt; David E Elder
Desmoplasia and neurotropism. Prognostic variables in patients with stage I melanoma.
Cancer 1995;76(11):2242-7.
1995: David E Elder
Skin cancer. Melanoma and other specific nonmelanoma skin cancers.
Cancer 1995;75(1 Suppl):245-56.
1995: Patricia Hartge; E A Holly; Allan C Halpern; R Sagebiel; DuPont Guerry; David E Elder; W Clark; L Hanson; C Harrison; Robert E Tarone
Recognition and classification of clinically dysplastic nevi from photographs: a study of interobserver variation.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1995;4(1):37-40.
1994: W P Carey; C J Thompson; Marie Synnestvedt; DuPont Guerry; Allan C Halpern; D Schultz; David E Elder
Dysplastic nevi as a melanoma risk factor in patients with familial melanoma.
Cancer 1994;74(12):3118-25.
1994: Ie-Ming Shih; David E Elder; Mei-Yu Hsu; Meenhard Herlyn
Regulation of Mel-CAM/MUC18 expression on melanocytes of different stages of tumor progression by normal keratinocytes.
The American journal of pathology 1994;145(4):837-45.
1994: K Isshiki; B A Seng; David E Elder; D Guerry; A J Linnenbach
Chromosome 9 deletion in sporadic and familial melanomas in vivo.
Oncogene 1994;9(6):1649-53.
1994: Michael Piepkorn; R L Barnhill; Lisa A Cannon-Albright; David E Elder; David E Goldgar; C M Lewis; J C Maize; Laurence J Meyer; M S Rabkin; R W Sagebiel
A multiobserver, population-based analysis of histologic dysplasia in melanocytic nevi.
Journal of the American Academy of Dermatology 1994;30(5 Pt 1):707-14.
1994: Allan C Halpern; Lynn Schuchter; David E Elder; DuPont Guerry; Rosalie Elenitsas; Bruce J Trock; I Matozzo
Effects of topical tretinoin on dysplastic nevi.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(5):1028-35.
1994: Ie-Ming Shih; David E Elder; D Speicher; J P Johnson; Meenhard Herlyn
Isolation and functional characterization of the A32 melanoma-associated antigen.
Cancer research 1994;54(9):2514-20.
1993: D Duke; J Castresana; L Lucchina; T H Lee; Arthur J Sober; W P Carey; David E Elder; R L Barnhill
Familial cutaneous melanoma and two-mutational-event modeling.
Cancer 1993;72(11):3239-43.
1993: K Isshiki; David E Elder; D Guerry; A J Linnenbach
Chromosome 10 allelic loss in malignant melanoma.
Genes, chromosomes & cancer 1993;8(3):178-84.
1993: I Juhasz; Steven M Albelda; David E Elder; George F Murphy; K Adachi; D Herlyn; I T Valyi-Nagy; Meenhard Herlyn
Growth and invasion of human melanomas in human skin grafted to immunodeficient mice.
The American journal of pathology 1993;143(2):528-37.
1993: Allan C Halpern; DuPont Guerry; David E Elder; Bruce J Trock; Marie Synnestvedt; T Humphreys
Natural history of dysplastic nevi.
Journal of the American Academy of Dermatology 1993;29(1):51-7.
1993: I Valyi-Nagy; Ie-Ming Shih; T Györfi; D Greenstein; I Juhasz; David E Elder; Meenhard Herlyn
Spontaneous and induced differentiation of human melanoma cells.
International journal of cancer. Journal international du cancer 1993;54(1):159-65.
1993: Margaret A Tucker; Mary C Fraser; Alisa M Goldstein; David E Elder; DuPont Guerry; S M Organic
Risk of melanoma and other cancers in melanoma-prone families.
The Journal of investigative dermatology 1993;100(3):350S-355S.
1993: Allan C Halpern; DuPont Guerry; David E Elder; Bruce J Trock; Marie Synnestvedt
A cohort study of melanoma in patients with dysplastic nevi.
The Journal of investigative dermatology 1993;100(3):346S-349S.
1993: DuPont Guerry; Marie Synnestvedt; David E Elder; D Schultz
Lessons from tumor progression: the invasive radial growth phase of melanoma is common, incapable of metastasis, and indolent.
The Journal of investigative dermatology 1993;100(3):342S-345S.
1993: B Lazzaro; David E Elder; A Rebers; L Power; Meenhard Herlyn; A Menrad; B Johnson
Immunophenotyping of compound and spitz nevi and vertical growth-phase melanomas using a panel of monoclonal antibodies reactive in paraffin sections.
The Journal of investigative dermatology 1993;100(3):313S-317S.
1993: M L Mancianti; T Györfi; Ie-Ming Shih; I Valyi-Nagy; G Levengood; Hans D Menssen; Allan C Halpern; David E Elder; Meenhard Herlyn
Growth regulation of cultured human nevus cells.
The Journal of investigative dermatology 1993;100(3):281S-287S.
1993: David E Elder; W H Clark; Rosalie Elenitsas; DuPont Guerry; Allan C Halpern
The early and intermediate precursor lesions of tumor progression in the melanocytic system: common acquired nevi and atypical (dysplastic) nevi.
Seminars in diagnostic pathology 1993;10(1):18-35.
1992: David E Elder; R G Freeman; W F Bergfeld; A B Ackerman; H A Azar; R E Fechner; R Caputo; John S Metcalf; G Borroni; G Burg
Do you use the term "dysplasia"? If so, what do you mean by it, and if not, why not?
The American Journal of dermatopathology 1992;14(5):462-86.
1992: E J Miller; John M Daly; Marie Synnestvedt; D Schultz; David E Elder; DuPont Guerry
Loco-regional nodal relapse in melanoma.
Surgical oncology 1992;1(5):333-40.
1992: Virginia A LiVolsi; John J S Brooks; Robert A Soslow; B L Johnson; David E Elder
Signet cell melanocytic lesions.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1992;5(5):515-20.
1992: David E Elder; Meenhard Herlyn
Antigens associated with tumor progression in melanocytic neoplasia.
Pigment cell research / sponsored by the European Society for Pigment Cell Research and the International Pigment Cell Society 1992;Suppl 2():136-43.
1991: P León; John M Daly; Marie Synnestvedt; D J Schultz; David E Elder; W H Clark
The prognostic implications of microscopic satellites in patients with clinical stage I melanoma.
Archives of surgery (Chicago, Ill. : 1960) 1991;126(12):1461-8.
1991: David E Elder
Risk of spots.
The American Journal of dermatopathology 1991;13(6):630-1.
1991: Allan C Halpern; DuPont Guerry; David E Elder; W H Clark; Marie Synnestvedt; Sandra A Norman; R Ayerle
Dysplastic nevi as risk markers of sporadic (nonfamilial) melanoma. A case-control study.
Archives of dermatology 1991;127(7):995-9.
1990: Steven M Albelda; S A Mette; David E Elder; R Stewart; L Damjanovich; Meenhard Herlyn; CA Buck
Integrin distribution in malignant melanoma: association of the beta 3 subunit with tumor progression.
Cancer research 1990;50(20):6757-64.
1990: S W Atlas; B H Braffman; R LoBrutto; David E Elder; D Herlyn
Human malignant melanomas with varying degrees of melanin content in nude mice: MR imaging, histopathology, and electron paramagnetic resonance.
Journal of computer assisted tomography 1990;14(4):547-54.
1990: G D Masri; Wallace H Clark; DuPont Guerry; Allan C Halpern; C J Thompson; David E Elder
Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier disease.
Journal of the American Academy of Dermatology 1990;22(6 Pt 1):1042-8.
1989: W H Clark; David E Elder; DuPont Guerry; L E Braitman; Bruce J Trock; D Schultz; Marie Synnestvedt; Allan C Halpern
Model predicting survival in stage I melanoma based on tumor progression.
Journal of the National Cancer Institute 1989;81(24):1893-904.
1989: David E Elder; Ulrich Rodeck; J Thurin; F Cardillo; W H Clark; R Stewart; Meenhard Herlyn
Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
Cancer research 1989;49(18):5091-6.
1989: R Kath; Ulrich Rodeck; Hans D Menssen; M L Mancianti; A J Linnenbach; David E Elder; Meenhard Herlyn
Tumor progression in the human melanocytic system.
Anticancer research 1989;9(4):865-72.
1989: David E Elder
Human melanocytic neoplasms and their etiologic relationship with sunlight.
The Journal of investigative dermatology 1989;92(5 Suppl):297S-303S.
1989: K R Cooke; G F Spears; David E Elder; M H Greene
Dysplastic naevi in a population-based survey.
Cancer 1989;63(6):1240-4.
1988: David E Elder
Dysplastic nevus syndrome--biological significance.
Seminars in oncology 1988;15(6):529-40.
1988: David E Elder
Dysplastic nevi. Their significance and management.
Dermatologic clinics 1988;6(2):257-69.
1987: J A Shields; David E Elder; V Arbizo; T Hedges; J J Augsburger
Orbital involvement with desmoplastic melanoma.
The British journal of ophthalmology 1987;71(4):279-84.
1987: M H Greene; Margaret A Tucker; Wallace H Clark; K H Kraemer; David E Elder; Mary C Fraser
Hereditary melanoma and the dysplastic nevus syndrome: the risk of cancers other than melanoma.
Journal of the American Academy of Dermatology 1987;16(4):792-7.
1987: M J Kornstein; R Stewart; David E Elder
Natural killer cells in the host response to melanoma.
Cancer research 1987;47(5):1411-2.
1987: J Thurin; M Thurin; Y Kimoto; M Herlyn; M D Lubeck; David E Elder; M Smereczynska; K A Karlsson; W M Clark; Z Steplewski
Monoclonal antibody-defined correlations in melanoma between levels of GD2 and GD3 antigens and antibody-mediated cytotoxicity.
Cancer research 1987;47(5):1229-33.
1986: K H Kraemer; M Tucker; R Tarone; David E Elder; W H Clark
Risk of cutaneous melanoma in dysplastic nevus syndrome types A and B.
The New England journal of medicine 1986;315(25):1615-6.
1986: J Thurin; M Thurin; M Herlyn; David E Elder; Z Steplewski; W H Clark; H Koprowski
GD2 ganglioside biosynthesis is a distinct biochemical event in human melanoma tumor progression.
FEBS letters 1986;208(1):17-22.
1986: Wallace H Clark; David E Elder; M Van Horn
The biologic forms of malignant melanoma.
Human pathology 1986;17(5):443-50.
1986: L I Goldman; David E Elder; W H Clark; M J Mastrangelo; J Stennett
Assessment of survival rates with metastatic malignant melanomas.
Surgery, gynecology & obstetrics 1986;162(3):199-203.
1986: D Herlyn; David E Elder; E Bondi; B Atkinson; DuPont Guerry; H Koprowski; Wallace H Clark
Human cutaneous nevi transplanted onto nude mice: a model for the study of the lesional steps in tumor progression.
Cancer research 1986;46(3):1339-43.
1985: J Thurin; M Herlyn; O Hindsgaul; Nicklas Strömberg; Karl-Anders Karlsson; David E Elder; Z Steplewski; H Koprowski
Proton NMR and fast-atom bombardment mass spectrometry analysis of the melanoma-associated ganglioside 9-O-acetyl-GD3.
The Journal of biological chemistry 1985;260(27):14556-63.
1985: Meenhard Herlyn; J Thurin; G Balaban; Jeannette L Bennicelli; D Herlyn; David E Elder; E Bondi; DuPont Guerry; Peter C Nowell; Wallace H Clark
Characteristics of cultured human melanocytes isolated from different stages of tumor progression.
Cancer research 1985;45(11 Pt 2):5670-6.
1985: David E Elder
The blind men and the elephant. Different views of small congenital nevi.
Archives of dermatology 1985;121(10):1263-5.
1985: David E Elder; DuPont Guerry; M VanHorn; S Hurwitz; L Zehngebot; L I Goldman; D LaRossa; R Hamilton; E E Bondi; Wallace H Clark
The role of lymph node dissection for clinical stage I malignant melanoma of intermediate thickness (1.51-3.99 mm).
Cancer 1985;56(2):413-8.
1985: David E Elder
Distinguishing cancer and noncancer.
The Journal of investigative dermatology 1985;85(1):1-3.
1985: David E Elder
The dysplastic nevus.
Pathology 1985;17(2):291-7.
1985: M H Greene; Wallace H Clark; Margaret A Tucker; K H Kraemer; David E Elder; Mary C Fraser
High risk of malignant melanoma in melanoma-prone families with dysplastic nevi.
Annals of internal medicine 1985;102(4):458-65.
1985: Meenhard Herlyn; G Balaban; Jeannette L Bennicelli; DuPont Guerry; R Halaban; D Herlyn; David E Elder; G G Maul; Z Steplewski; Peter C Nowell
Primary melanoma cells of the vertical growth phase: similarities to metastatic cells.
Journal of the National Cancer Institute 1985;74(2):283-9.
1985: M H Greene; Wallace H Clark; Margaret A Tucker; David E Elder; K H Kraemer; DuPont Guerry; W K Witmer; J Thompson; I Matozzo; Mary C Fraser
Acquired precursors of cutaneous malignant melanoma. The familial dysplastic nevus syndrome.
The New England journal of medicine 1985;312(2):91-7.
1985: A B Ackerman; David E Elder
An exchange of ideas about dysplastic nevi and malignant melanomas.
The American Journal of dermatopathology 1985;7 Suppl():99-105.
1984: Wallace H Clark; David E Elder; DuPont Guerry; M N Epstein; M H Greene; M Van Horn
A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma.
Human pathology 1984;15(12):1147-65.
1984: A H Ross; P Grob; Mark Bothwell; David E Elder; C S Ernst; N Marano; B F Ghrist; C C Slemp; Meenhard Herlyn; B Atkinson
Characterization of nerve growth factor receptor in neural crest tumors using monoclonal antibodies.
Proceedings of the National Academy of Sciences of the United States of America 1984;81(21):6681-5.
1984: M R Taylor; DuPont Guerry; E E Bondi; J A Shields; J J Augsburger; E J Lusk; David E Elder; Wallace H Clark; M Van Horn
Lack of association between intraocular melanoma and cutaneous dysplastic nevi.
American journal of ophthalmology 1984;98(4):478-82.
1984: M H Greene; Wallace H Clark; Margaret A Tucker; David E Elder; K H Kraemer; DuPont Guerry; Mary C Fraser
Managing the dysplastic naevus syndrome.
Lancet 1984;1(8369):166-7.
1984: M H Greene; Mary C Fraser; Wallace H Clark; David E Elder; DuPont Guerry; K H Kraemer
For the record: the history of precursors to malignant melanoma.
Archives of dermatology 1984;120(1):18-21.
1984: David E Elder; D Guerry; M N Epstein; L Zehngebot; E Lusk; M Van Horn; W H Clark
Invasive malignant melanomas lacking competence for metastasis.
The American Journal of dermatopathology 1984;6 Suppl():55-61.
1984: David E Elder
Making orderly the disorderly nevus.
The American Journal of dermatopathology 1984;6 Suppl():175-6.
1984: David E Elder; D Guerry
On widths of margins in excision of primary malignant melanomas. Ethics of randomized trials of wide and narrow margins.
The American Journal of dermatopathology 1984;6 Suppl():131-3.
1983: K H Kraemer; M H Greene; R Tarone; David E Elder; W H Clark; DuPont Guerry
Dysplastic naevi and cutaneous melanoma risk.
Lancet 1983;2(8358):1076-7.
1983: E E Bondi; David E Elder; DuPont Guerry; Wallace H Clark
Target blue nevus.
Archives of dermatology 1983;119(11):919-20.
1983: Meenhard Herlyn; D Herlyn; David E Elder; E Bondi; D LaRossa; R Hamilton; H F Sears; G Balaban; DuPont Guerry; Wallace H Clark
Phenotypic characteristics of cells derived from precursors of human melanoma.
Cancer research 1983;43(11):5502-8.
1983: M H Greene; L R Goldin; Wallace H Clark; E Lovrien; K H Kraemer; M A Tucker; David E Elder; Mary C Fraser; S Rowe
Familial cutaneous malignant melanoma: autosomal dominant trait possibly linked to the Rh locus.
Proceedings of the National Academy of Sciences of the United States of America 1983;80(19):6071-5.
1983: M H Greene; R J Sanders; F C Chu; W H Clark; David E Elder; D G Cogan
The familial occurrence of cutaneous melanoma, intraocular melanoma, and the dysplastic nevus syndrome.
American journal of ophthalmology 1983;96(2):238-45.
1983: E E Bondi; David E Elder; DuPont Guerry; Wallace H Clark
Skin markings in malignant melanoma.
JAMA : the journal of the American Medical Association 1983;250(4):503-5.
1983: Margaret A Tucker; M H Greene; Wallace H Clark; K H Kraemer; Mary C Fraser; David E Elder
Dysplastic nevi on the scalp of prepubertal children from melanoma-prone families.
The Journal of pediatrics 1983;103(1):65-9.
1983: M J Kornstein; J S Brooks; David E Elder
Immunoperoxidase localization of lymphocyte subsets in the host response to melanoma and nevi.
Cancer research 1983;43(6):2749-53.
1983: David E Elder; D Guerry; R M Heiberger; D LaRossa; L I Goldman; W H Clark; C J Thompson; I Matozzo; M Van Horn
Optimal resection margin for cutaneous malignant melanoma.
Plastic and reconstructive surgery 1983;71(1):66-72.
1982: David E Elder; M H Green; D Guerry; K H Kraemer; W H Clark
The dysplastic nevus syndrome: our definition.
The American Journal of dermatopathology 1982;4(5):455-60.
1982: David E Elder; P M Jucovy; W H Clark
Melanoma classification: a testable hypothesis.
The American Journal of dermatopathology 1982;4(5):443-5.
1982: J J Thompson; M F Herlyn; David E Elder; W H Clark; Z Steplewski; H Koprowski
Use of monoclonal antibodies in detection of melanoma-associated antigens in intact human tumors.
The American journal of pathology 1982;107(3):357-61.
1982: J J Thompson; M F Herlyn; David E Elder; W H Clark; Z Steplewski; H Koprowski
Expression of DR antigens in freshly frozen human tumors.
Hybridoma 1982;1(2):161-8.
1981: E E Bondi; Wallace H Clark; David E Elder; DuPont Guerry; M H Greene
Topical chemotherapy of dysplastic melanocytic nevi with 5% fluorouracil.
Archives of dermatology 1981;117(2):89-92.
1980: M H Greene; Wallace H Clark; Margaret A Tucker; David E Elder; K H Kraemer; Mary C Fraser; E E Bondi; DuPont Guerry; R Tuthill; R Hamilton; D LaRossa
Precursor naevi in cutaneous malignant melanoma: a proposed nomenclature.
Lancet 1980;2(8202):1024.
1980: David E Elder; L I Goldman; S C Goldman; M H Greene; Wallace H Clark
Dysplastic nevus syndrome: a phenotypic association of sporadic cutaneous melanoma.
Cancer 1980;46(8):1787-94.
1980: Meenhard Herlyn; Wallace H Clark; M J Mastrangelo; DuPont Guerry; David E Elder; D LaRossa; R Hamilton; E Bondi; R Tuthill; Z Steplewski; H Koprowski
Specific immunoreactivity of hybridoma-secreted monoclonal anti-melanoma antibodies to cultured cells and freshly derived human cells.
Cancer research 1980;40(10):3602-9.
1980: David E Elder; P M Jucovy; R J Tuthill; W H Clark
The classification of malignant melanoma.
The American Journal of dermatopathology 1980;2(4):315-20.